Q4652489
Sign in to saveAM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
~2 min read
Encyclopedic overview
7 sectionsContents
- Hazards
- Pharmacology
- Pharmacokinetics
- Detection
- Legal status
- See also
- References
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
==Hazards== Convulsions have been reported including at doses as low as 10 mg.
Excerpted from Wikipedia’s “Q4652489” article, available under the CC BY-SA 4.0 licence.